EMD Serono picks market access senior VP

Robert Truckenmiller is now senior VP, Market Access & Customer Solutions. In this role, Truckenmiller will oversee the development of U.S. market access strategy and implementation, as well as payer contracting and reimbursement strategies, to enable patient access to EMD Serono medications.

Truckenmiller joined EMD Serono in July 2016 as VP, Market Access & Customer Solutions, where he implemented new processes and procedures to optimize development and operations of all EMD Serono contracted business.

“Rob has demonstrated tremendous knowledge of the payer landscape, offering strategic insights and creating processes to ensure patients receive the medications they need,” says Gary Zieziula, president and managing director of EMD Serono. “With his strong track record, I know Rob will successfully lead EMD Serono in delivering meaningful therapies to people with difficult to treat diseases.”

Prior to EMD Serono, Truckenmiller served as VP and head of U.S. Market Access & Pricing at UCB, where he led a large team in developing a market access strategy that successfully improved overall patient access to UCB brands. He spent 11 years at UCB, taking on roles of increasing responsibility across market access and brand marketing. Additionally, he has more than 15 years of experience in the biopharmaceutical industry in various sales and marketing roles at companies such as Johnson & Johnson and DaVita Kidney Care.

Truckenmiller succeeds Scott Filosi, who was recently appointed to a new position within Merck KGaA, Darmstadt, Germany, as the head of Global Market Access & Pricing.

Truckenmiller holds an undergraduate degree in marketing and an MBA in finance and financial management services from University of Central Florida – College of Business Administration.